On the recordSeptember 18, 2023
Do PBMs often exclude lower-cost generics in favor of high-cost branded drugs, effectively eliminating the benefit of the short patent on drugs?
Source
congress.govDo PBMs often exclude lower-cost generics in favor of high-cost branded drugs, effectively eliminating the benefit of the short patent on drugs?
Mace questions the practices of PBMs regarding drug pricing.
Share
More from Nancy Mace
This is about the victims getting the evidence and documentation for themselves that the DOJ is denying them, and then also the AGs in different states should be able to pursue this, particularly New Mexico.
Darline, darlin’, you are running for the United States Senate. National security isn’t just a thing. It is damn near the only thing.
This is the part that should worry you. On that one question, she had an answer, and it was yes.